project id: TCGA-CESC; case submitter id: TCGA-EK-A2IR; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 7.0; age at index: 48; days to birth: -17581; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 17581; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic t: T1b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3442.0; figo stage: Stage IB2; icd 10 code: C53.9; last known disease status: not reported; morphology: 8071/3; primary diagnosis: Squamous cell carcinoma, keratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 1997; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.9863013698630136; pack years smoked: 18.0; is ffpe: false; composition: Not Reported; days to collection: 4950; initial weight: 130.0; oct embedded: false; preservation method: Unknown; sample id: d4e7991a-90ec-4248-8c62-28e816edad48; sample submitter id: TCGA-EK-A2IR-01A; portion id: 42c07afb-0c6f-4d57-aa6e-90fd216239c7; portion submitter id: TCGA-EK-A2IR-01A-11; slide id: f555e682-07f5-4626-beeb-3ee33df5e6d1; slide submitter id: TCGA-EK-A2IR-01A-01-TSA; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 79.0; percent tumor nuclei: 90.0; section location: TOP;